Cargando…
Sirolimus-Based Immunosuppression as GvHD Prophylaxis after Bone Marrow Transplantation for Severe Aplastic Anaemia: A Case Report and Review of the Literature
Congenital or acquired severe aplastic anaemia (SAA) is cured by bone marrow transplantation (BMT) from a histocompatible leukocyte antigen- (HLA-) identical sibling. The best conditioning regimen is cyclophosphamide (CTX) with or without antithymocyte globulin (ATG), followed by short-term methotre...
Autores principales: | Perruccio, Katia, Mastrodicasa, Elena, Arcioni, Francesco, Capolsini, Ilaria, Cerri, Carla, Gurdo, Grazia, Caniglia, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299786/ https://www.ncbi.nlm.nih.gov/pubmed/25628902 http://dx.doi.org/10.1155/2015/321602 |
Ejemplares similares
-
Inflammasome effects in GvHD
por: Koehn, Brent H., et al.
Publicado: (2015) -
Editorial: Interferons and GvHD
por: Kim, Boram, et al.
Publicado: (2022) -
Antibody- and aptamer-strategies for GvHD prevention
por: Oelkrug, Christopher, et al.
Publicado: (2015) -
Established and Emerging Treatments of Skin GvHD
por: Link-Rachner, Cornelia S., et al.
Publicado: (2022) -
Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD
por: Buxbaum, Nataliya P., et al.
Publicado: (2022)